Investors in Revance Therapeutics, Inc. Should Contact The Gross Law Firm Before March 4, 2025 to Discuss Your Rights - RVNC
Portfolio Pulse from
The Gross Law Firm has issued a notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC) to contact them before March 4, 2025, regarding potential lead plaintiff appointment in a class action lawsuit.
February 13, 2025 | 11:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Revance Therapeutics shareholders are advised to contact The Gross Law Firm by March 4, 2025, for potential involvement in a class action lawsuit.
The notice from The Gross Law Firm suggests potential legal issues for Revance Therapeutics, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100